Skip to main content

Advertisement

SpringerLink
Log in

The relationship between high-sensitivity C-reactive protein and ApoB, ApoB/ApoA1 ratio in general population of China

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Inflammatory biomarker high-sensitivity C-reactive protein (hsCRP) is considered as a major predictor of cardiovascular events. Apolipoprotein B (ApoB) directly reflects the number of plasma atherogenic lipoproteins, and may play a major role in vascular inflammation. We aimed to assess whether an association between ApoB and hsCRP exists and, furthermore, to examine whether ApoB is more predictive of the inflammatory status than other cardiovascular risk factors. This was a cross-sectional study, with 511 apparently healthy adult subjects enrolled. Waist circumference (WC), body mass index (BMI), and blood pressure (BP) were measured. Plasma glucose levels, hsCRP, lipid profile, and insulin were collected after 10–14 h fasting. From the lowest to the highest quartile of hsCRP, the values for BMI, WC, BP, HOMA-IR, insulin, glucose level, triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), ApoB and the ApoB/apolipoprotein A1 (ApoA1) ratio were increased as the hsCRP level increased (P < 0.01), and high-density lipoprotein cholesterol (HDL-C) and ApoA1 levels declined as hsCRP level increased (P < 0.0001). Pearson’s correlation analysis demonstrated that hsCRP correlated with all variables (P < 0.01), except for total cholesterol (TC) (P = 0.154) and LDL-C (P = 0.087). According to forward stepwise regression analysis with hsCRP as the dependent variable, WC was the only variable entered the regression model. ApoB level correlated with hsCRP level but was not the major determinant of hsCRP. WC was stronger than other cardiovascular risk factors in the associations with hsCRP. Abdominal obesity rather than atherogenic dyslipidemia was the primary cause of chronic inflammatory status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. S.S. Bassuk, N. Rifai, P.M. Ridker, High-sensitivity C-reactive protein: clinical importance. Curr. Probl. Cardiol. 29, 439–493 (2004)

    PubMed  Google Scholar 

  2. P.M. Ridker, N. Rifai, L. Rose, J.E. Burning, N.R. Cook, Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347, 1557–1565 (2002)

    Article  PubMed  CAS  Google Scholar 

  3. F. Haverkate, S.G. Thompson, S.D. Pyke, J.R. Gallimore, M.B. Pepys, Production of C-reactive protein and risk of coronary in stable and unstable angina. European concerted action on thrombosis and disabilities angina pectoris study group. Lancet 349, 462–466 (1997)

    Article  PubMed  CAS  Google Scholar 

  4. M. Faraj, L. Messier, J.P. Bastard, A. Tardif, A. Godbout, D. Prud’homme, R. Rabasa-Lhoret, Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women. Diabetologia 49, 1637–1646 (2006)

    Article  PubMed  CAS  Google Scholar 

  5. J. Fan, T. Watanabe, Inflammatory reactions in the pathogenesis of atherosclerosis. J. Atheroscler. Thromb. 10, 63–71 (2003)

    Article  PubMed  CAS  Google Scholar 

  6. J. Sierra-Johnson, R.M. Fisher, A. Romero-Corral, V.K. Somers, F. Lopez-Jinmenez, J. Ohrvik, G. Walldius, M.L. Hellenius, A. Hamsten, Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. Eur. Heart J. 30, 710–717 (2009)

    Article  PubMed  CAS  Google Scholar 

  7. Joint committee for developing chinese guidelines on prevention and treatment of dyslipidemia in adults, Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chin. J. Cardiol. 35, 390–419 (2007). (in Chinese)

    Google Scholar 

  8. A.R. Sharret, C.M. Ballantyne, S.A. Coady, G. Heiss, P.D. Sorlie, D. Catellier, W. Patsch, Artheroscleosis risk in communities study group. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study. Circulation 104, 1108–1113 (2001)

    Article  Google Scholar 

  9. W.E. Boden, High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the veterans affairs high-density lipoprotein intervention trial. Am. J. Cardiol. 86, 19L–22L (2000)

    Article  PubMed  CAS  Google Scholar 

  10. G.W. Cockerill, K.A. Ryw, J.R. Gamble, M.A. Vadas, P.J. Barter, High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15, 1987–1994 (1995)

    Article  PubMed  CAS  Google Scholar 

  11. N. Hyka, J.M. Dayer, C. Modoux, T. Kohno, C.K. Edwards 3rd, P. Roux-Lombard, D. Burger, Apolipoprotein A-I inhibits the production of interleukin-1 beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97, 2381–2389 (2000)

    Article  Google Scholar 

  12. C.C. Hedrick, S.R. Thorpe, M.X. Fu, C.M. Harper, J. Yoo, S.M. Kim, H. Wong, A.L. Perers, Glycation impairs high-density lipoprotein function. Diabetologia 43, 312–320 (2000)

    Article  PubMed  CAS  Google Scholar 

  13. L. Perségol, B. Vergès, P. Gambert, L. Duvillard, Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation. J. Lipid Res. 48, 1396–1401 (2007)

    Article  PubMed  Google Scholar 

  14. T. Pischon, C.J. Girman, F.M. Sacks, N. Rifai, M.J. Stampfer, E.B. Rimm, Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 112, 3375–3383 (2005)

    Article  PubMed  CAS  Google Scholar 

  15. K.L. Chien, H.C. Hsu, T.C. Su, M.F. Chen, Y.T. Lee, F.B. Hu, Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese. J. Lipid Res. 48, 2499–2505 (2007)

    Article  PubMed  CAS  Google Scholar 

  16. A.E. Hak, C.D. Stehouwer, M.L. Bots, K.H. Polderman, C.G. Schalkwijk, I.C. Westendorp, A. Hofman, J.C. Witteman, Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler. Thromb. Vasc. Biol. 19, 1986–1991 (1999)

    Article  PubMed  CAS  Google Scholar 

  17. I. Lemieux, A. Pascot, D. Prud’homme, N. Almėras, P. Bogaty, A. Nadeau, J. Bergeron, J.P. Desprės, Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler. Thromb. Vasc. Biol. 21, 961–967 (2001)

    Article  PubMed  CAS  Google Scholar 

  18. Y. Mugabo, L. Li, G. Renier, The connection between C-reactive protein (CRP) and diabetic vasculopay. Focus on preclinical findings. Curr. Diabetes Rev. 6, 27–34 (2010)

    Article  PubMed  CAS  Google Scholar 

  19. K. Brochu-gaudrea, C. Rehfeldt, R. Blouin, V. Bordignon, B.D. Murphy, M.F. Palin, Adiponectin action from head to toe. Endocrine 37, 11–32 (2010)

    Article  Google Scholar 

  20. J.B. Li, A. Asakawa, K.C. Cheng, Y. Li, H. Chaolu, M. Tsai, A. Inui, Biological effects of obestatin. Endocrine 39, 205–211 (2011)

    Article  PubMed  CAS  Google Scholar 

  21. I. Castan-Lsurell, C. Dray, C. Arranė, T. Duparc, C. Knauf, P. Valet, Apelin, diabetes, and obesity. Endocrine 40, 1–9 (2011)

    Article  Google Scholar 

Download references

Acknowledgments

This research was supported by grants from Chongqing Sciences and Technology Commission (grants no. 09BB5076). We thank Professor Yonghong Wang (Department of medical examination center, the First Affiliated Hospital of Chongqing Medical University) for help with collecting the specimen in her directions. We also thank Dr. Xiaojun Tang (Department of Epidemiology, Chongqing Medical University) for her advice on the statistical analysis of the data.

Institutional approval

This study was approved by the Research Ethics Committee of the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Author information

Authors and Affiliations

  1. Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Street, Chongqing, 400016, China

    Wanhua Xu, Rong Li, Suhua Zhang, Lilin Gong, Zhihong Wang, Wei Ren, Chenxi Xia & Qifu Li

  2. Department of Emergency, The First People’s Hospital of Foshan, No.81 North of Lingnan Road, Foshan, 528000, Guangdong, China

    Wanhua Xu

Authors
  1. Wanhua Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Suhua Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lilin Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhihong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wei Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chenxi Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Qifu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rong Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, W., Li, R., Zhang, S. et al. The relationship between high-sensitivity C-reactive protein and ApoB, ApoB/ApoA1 ratio in general population of China. Endocrine 42, 132–138 (2012). https://doi.org/10.1007/s12020-012-9599-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-012-9599-x

Keywords

Search

Navigation